Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
Warning: file_get_contents(http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=17162353&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 445
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
NK cells and type 1 diabetes Rodacki M; Milech A; de Oliveira JEClin Dev Immunol 2006[Jun]; 13 (2-4): 101-7Type 1 diabetes (T1D) is characterized by an immuno-mediated progressive destruction of the pancreatic beta cells. Due to the ability of NK cells to kill target cells as well as to interact with antigen-presenting and T cells, it has been suggested that they could be involved in one or multiple steps of the immune-mediated attack that leads to T1D. Abnormalities in the frequency and activity of NK cells have been described both in animal models and patients with T1D. Some of these alterations are linked to its onset while others seem to be a consequence of the disease. Here, we discuss the main characteristics of NK cells and review the studies that investigated the role of NK cells in T1D, both in mouse models and humans.|Animals[MESH]|Antigen-Presenting Cells/immunology[MESH]|Autoantibodies/metabolism[MESH]|Autoimmunity/immunology[MESH]|Diabetes Mellitus, Type 1/*immunology/*pathology[MESH]|Genetic Predisposition to Disease[MESH]|Humans[MESH]|Killer Cells, Natural/*immunology/metabolism[MESH]|T-Lymphocyte Subsets/*immunology/metabolism[MESH] |
